Advarra Announces Site IQ
Advarra has announced the launch of Site IQ. The platform builds on Advarra's experience as the provider of practice management solutions for clinical research to deliver an integrated set of site and principal investigator insights to enable smarter site selection. The Site IQ platform provides customized data analysis to help sponsors and CROs make informed decisions in their investigative site selection and feasibility processes.
Advarra Site IQ delivers insights to drive study startup by supporting protocol planning and site selection processes. Site IQ informs intelligent site selection by leveraging comprehensive data across experience, capacity, quality, performance, and patient eligibility. Data is derived from Advarra's data as well as third-party partner data. As such, Site IQ reflects insights based on actual study and performance data, not estimates or self-reported information.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
